- Raised $2.2M Seed round led by Shoni Health Ventures, Oct 2025
About
Levron Cardiovascular is an Israeli medical device startup developing a novel autonomic integrated diagnostic and therapeutic minimally invasive device for heart failure patients. The company's proprietary Cardio-Respiratory Physiology Assist (CRPA) technology, branded as "Soulmate", aims to synchronize heart and lung activity to alleviate pulmonary congestion, reduce cardiac workloads, and improve outcomes for patients with both reduced and preserved ejection fraction heart failure. The technology leverages the physiological link between the heart and lungs, using the natural 'respiratory pump' to assist cardiac function. Levron Medical's approach is designed to combine the clinical impact of traditional medical devices with faster development cycles and lower costs. The company formally exited stealth mode in November 2025.
Funding history · 1 round · $2.2M total
Headcount over time
Q&A
- What is Levron Cardiovascular's primary focus?
- Levron Cardiovascular is developing a novel autonomic integrated diagnostic and therapeutic minimally invasive device for patients with cardiac failure, specifically targeting NYHA stage 3 heart failure to eliminate lung congestion.
- When was Levron Cardiovascular founded?
- Levron Cardiovascular was founded in June 2021.
- What is the current employee count for Levron Cardiovascular?
- Levron Cardiovascular has 1-10 employees.
- What is the total amount of funding raised by Levron Cardiovascular to date?
- Levron Cardiovascular has raised a total of $2,200,000.
- When did Levron Cardiovascular complete its last funding round?
- Levron Cardiovascular completed a funding round in November 2025, raising $2,200,000.
- Which investors participated in Levron Cardiovascular's November 2025 funding round?
- The November 2025 funding round for Levron Cardiovascular included.
- What sector does Levron Cardiovascular primarily operate in?
- Levron Cardiovascular primarily operates in the Health Tech & Life Sciences sector.
- What is the current product stage of Levron Cardiovascular's device?
- Levron Cardiovascular's device is currently in the clinical trial stage.
Team · 3
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | levron-medical.com/ |
|---|---|
| linkedin.com/company/77039918 |
Identifiers & details
| Legal name | Levron Medical Ltd. |
|---|---|
| Founded | 2021-6 |
| Employees (exact) | 5 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | levron-medical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516414950 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2021-06-15 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 2 — people (1), annual_report (1) |
| Registered address | התנופה 3 יקנעם עילית |
Recent registry events
| Date | Event |
|---|---|
| 2025-08-31 | עדכון דירקטורים-הוספת דירקטור |
| 2025-08-26 | דו~ח שנתי |